In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ironwood to co-promote AstraZeneca's Nexium in the US

Executive Summary

Ironwood Pharmaceuticals Inc. is gaining great visibility for itself amongst gastrointestinal practitioners through a new co-promotion agreement with AstraZeneca PLC. Ironwood will use its 160-strong sales force to detail the Big Pharma’s gastroesophageal reflux disease (GERD) drug Nexium (esomeprazole magnesium) in the US.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Marketing (Licensing)
    • Reverse Licensing

Related Companies